“Let Them Eat Cake”: Harm Reduction Edition
In recent weeks, the government of France decided to ban the sales, use, possession, import, and distribution of any oral nicotine products. Violations carry penalties of up to five years in prison and a fine of up to 375,000 euros. For a country that has otherwise supported tobacco harm reduction, this is a step backward.
A Nation Quitting Combustion
The timing is striking. France is winning its war on smoking. Daily smoking among adults aged 18 to 75 fell from roughly 30 percent in 2000 to a historic low of 18.2 percent in 2024. That decline accelerated sharply after 2016, driven by plain packaging, steep price hikes, and the annual anti-tobacco event. Roughly four million fewer adults smoke daily than in 2014. The government’s stated goal is a smoke-free generation, with youth smoking below 10 percent by 2032.
Reduced-risk products have helped power this progress. In 2024, 8.4 percent of adults vaped, and 6.5 percent did so daily, and 97 percent of vapers were current or former smokers. Nearly half of vapers reported quitting cigarettes through vaping. France has wisely left e-liquids untaxed beyond a standard value-added tax, even rejecting a proposed vape tax in early 2026. That is harm reduction working as designed: tax combustion heavily, leave safer alternatives accessible.
The Pouch Is Not the Problem
Nicotine pouches exist on the safer end of the risk continuum. Chemical analysis shows that leading pouch brands contain no detectable tobacco-specific nitrosamines or polycyclic aromatic hydrocarbons, placing their toxicant profile in line with pharmaceutical nicotine replacement therapy and far below moist snuff. Pharmacokinetic research has determined that a 4-milligram pouch delivers nicotine comparably to a 4-milligram lozenge, with better tolerability. The cessation evidence base remains immature, with the relevant Cochrane review still in protocol form. But by every available toxicological measure, pouches are vastly less harmful than the cigarettes they could replace.
The youth concern is real but limited. France’s food and environmental safety agency recorded roughly 90 poison-center calls regarding nicotine pouches in 2023 and 2024, with 54 percent involving adolescents aged 12 to 17, resulting in 11 severe cases. Those incidents deserve a response. Yet against the backdrop of millions of consumers, poisonings remain rare and tied to marketing and weak age controls, not to the product’s inherent risk. France’s own surveys found no meaningful standalone pouch prevalence among youth, who overwhelmingly favored disposable vapes instead.
Why Prohibition Backfires
Banning a safer product, like nicotine pouches, while leaving cigarettes on shelves inverts the logic of harm reduction. Adult smokers who might have switched to pouches now face two legal options: keep smoking, or do without. France leaves combustible tobacco fully legal and merely taxes it. It leaves vaping untaxed. Then it threatens pouch users with prison. The risk signal is exactly backward. Enforcement compounds the problem, and the policy is difficult to police at the level of individual possession.
The Conseil d’État has already suspended the manufacturing and export provisions pending a full ruling. A ban without supply control invites a predictable outcome: an unregulated gray market with no age verification, no quality standards, and no nicotine-content limits. Prohibition does not eliminate demand; it hands demand to actors who answer to no regulator. Sweden, where roughly 6 percent of adults use pouches daily, and smoking is the lowest in Europe, has objected that the ban will turn travelers into criminals.
A Better Path
France did not need prohibition; it needed regulation. The tools were obvious and proportionate: a strict age limit with retailer enforcement, a cap on nicotine content per pouch, child-resistant packaging, plain or restricted labeling, and a firm ban on the youth-oriented social media marketing that drove the poisoning cases. This is the same risk-proportionate framework France already applies to vaping, and it works. It protects children without stranding adult smokers who deserve a way out of combustion.
The irony is hard to miss. A country celebrating record-low smoking is about to criminalize a product that could continue to push those numbers lower. Good public health policy follows the evidence on relative risk. France, on pouches, has chosen to ignore it. The disconnection between the needs of the people and those in power didn’t work out too well for Marie Antoinette, but in the case of banning nicotine pouches, it is the citizens of France who are most likely to suffer.